fbpx

Up to $1.1 Billion: Inside the Settlement Resolving Most of Philadelphia’s Risperdal Cases

According to settlement records, the settlement’s group expenses were $33 million, with additional costs expected to be incurred.

       

Related Articles

Responses

Your email address will not be published. Required fields are marked *